Breathe Easy in 2025: Ace Your Registered Nurse Respiratory Exam with Confidence!

Intravenous Vancomycin is primarily used for treating serious bacterial infections, particularly those caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Severe pneumonia often requires aggressive treatment, especially when there is a concern for multidrug-resistant organisms or when the patient is critically ill. In such cases, the use of Vancomycin ensures coverage against these organisms, addressing the need for effective treatment in a potentially life-threatening infection.

Severe pneumonia may present with respiratory failure, requiring more robust interventions, including hospitalization and intravenous antibiotics. The other conditions listed, such as mild bronchitis and chronic obstructive pulmonary disease, typically do not warrant the use of Vancomycin, as they are either viral in nature or managed with less intensive treatments. Acute respiratory distress syndrome, while critical, is often a result of other underlying causes, and the treatment focus is generally on supportive care and addressing the underlying issue rather than specific antibiotic therapy like Vancomycin.